Assessing the prevalence of PINK1 genetic variants in South African patients diagnosed with early- and late-onset Parkinson's disease

Biochemical and Biophysical Research Communications

Volumn 398, Issue 1, 2010, Pages 125-129

  Keyser, Rowena J ^a   Lesage, Suzanne ^b,c,d   Brice, Alexis ^b,c,d   Carr, Jonathan ^a   Bardien, Soraya ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b SORBONNE UNIVERSITÉ   (France)

^c INSERM   (France)

^d CNRS   (France)

Author keywords

E476K; HRM; Kinase domain; P305A; Parkinson's disease; PINK1; Y258X

Indexed keywords

ALANINE; GLUTAMIC ACID; LYSINE; PHOSPHOTRANSFERASE; PROLINE; PTEN INDUCED PUTATIVE KINASE 1; TYROSINE; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE SEQUENCE; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NEGRO; NUCLEOTIDE SEQUENCE; ONSET AGE; PARKINSON DISEASE; PINK1 GENE; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOUTH AFRICA;

ADOLESCENT; ADULT; AGE OF ONSET; AMINO ACID SEQUENCE; FEMALE; GENETIC VARIATION; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PARKINSON DISEASE; POINT MUTATION; PREVALENCE; PROTEIN KINASES; SEQUENCE DELETION; SOUTH AFRICA; YOUNG ADULT;

EID: 77954760851     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.049     Document Type: Article

References (37)

1. Valente E.M., Abou-Sleiman P.M., Caputo V., et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004, 304:1158-1160.
2. Gandhi S., Muqit M.M., Stanyer L., et al. PINK1 protein in normal human brain and Parkinson's disease. Brain 2006, 129:1720-1731.
3. Valente E.M., Salvi S., Ialongo T., et al. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann. Neurol. 2004, 56:336-341.
4. Ephraty L., Porat O., Israeli D., et al. Neuropsychiatric and cognitive features in autosomal-recessive early parkinsonism due to PINK1 mutations. Mov. Disord. 2007, 22:566-569.
5. Rogaeva E., Johnson J., Lang A.E., et al. Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. Arch. Neurol. 2004, 61:1898-1904.
6. Bonifati V., Rohé C.F., Breedveld G.J., et al. Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology 2005, 65:87-95.
7. Klein C., Djarmati A., Hedrich K., et al. PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism. Eur. J. Hum. Genet. 2005, 13:1086-1093.
8. Abou-Sleiman P.M., Muqit M.M., McDonald N.Q., et al. A heterozygous effect for PINK1 mutations in Parkinson's disease?. Ann. Neurol. 2006, 60:414-419.
9. Onyango I.G. Mitochondrial dysfunction and oxidative stress in Parkinson's disease. Neurochem. Res. 2008, 33:589-597.
10. Clark I.E., Dodson M.W., Jiang C., et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 2006, 441:1162-1166.
11. Park J., Lee S.B., Lee S., Kim Y., Song S., Kim S., et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 2006, 441:1157-1161.
12. Yang Y., Gehrke S., Imai Y., Huang Z., et al. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc. Natl. Acad. Sci. USA 2006, 103:10793-11078.
13. Petit A., Kawarai T., Paitel E., et al. Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J. Biol. Chem. 2005, 280:34025-34032.
14. Duchen M.R., Surin A., Jacobson J. Imaging mitochondrial function in intact cells. Methods Enzymol. 2003, 361:353-389.
15. Pridgeon J.W., Olzmann J.A., Chin L.S., Li L. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol. 2007, 5:e172.
16. Um J.W., Stichel-Gunkel C., Lübbert H., et al. Molecular interaction between parkin and PINK1 in mammalian neuronal cells. Mol. Cell. Neurosci. 2009, 40:421-432.
17. Beilina A., Van Der Brug M., Ahmad R., et al. Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc. Natl. Acad. Sci. USA 2005, 102:5703-5708.
18. Sim C.H., Lio D.S., Mok S.S., et al. C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Hum. Mol. Genet. 2006, 15:3251-3262.
19. Gibb W.R.G., Lees A.J. A comparison of clinical and pathological features of young-onset and old-onset Parkinson's disease. Neurology 1988, 38:1402-1406.
20. Bardien S., Keyser R.J., Yako Y., Lombard D., Carr J. Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease. Parkinsonism Relat. Disord. 2009, 15:116-121.
21. Wittwer C.T., Reed G.H., Gundry C.N. High-resolution genotyping by amplicon melting analysis using LCGreen. Clin. Chem. 2003, 49:853-860.
22. Erali M., Voelkerding K.V., Wittwer C.T. High resolution melting applications for clinical laboratory medicine. Exp. Mol. Pathol. 2008, 85:50-58.
23. Keyser R.J., Lombard D., Veikondis R., et al. Analysis of exon dosage using MLPA in South African Parkinson's disease patients. Neurogenetics 2010, 11:305-312.
24. Mills R.D., Sim C.H., Mok S.S., et al. Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1). J. Neurochem. 2008, 105:18-33. (Review).
25. 2+/calmodulin-dependent protein kinase kinase. Role of the arg-pro-rich insert domain. J. Biol. Chem. 1999, 274:15803-15810.
26. Rafie-Kolpin M., Chefalo P.J., Hussain Z., et al. Two heme-binding domains of heme-regulated eukaryotic initiation factor-2alpha kinase. N terminus and kinase insertion. J. Biol. Chem. 2000, 275:5171-5178.
27. Bardien S., Marsberg A., Keyser R., et al. LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson's disease patients. J. Neural. Transm. 2010, 117:847-853.
28. Chaudhuri K.R., Hu M.T., Brooks D.J. Atypical parkinsonism in Afro-Caribbean and Indian origin immigrants to the UK. Mov. Disord. 2000, 15:18-23.
29. Silvestri L., Caputo V., Bellacchio E., et al. Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum. Mol. Genet. 2005, 14:3477-3492.
30. Marongiu R., Ferraris A., Ialongo T., et al. PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum. Hum. Mutat. 2008, 29:565-576.
31. Godeiro C., Aguiar P.M., Felício A.C., et al. PINK1 polymorphism IVS1-7 A→G, exposure to environmental risk factors and anticipation of disease onset in Brazilian patients with early-onset Parkinson's Disease. Neurosci. Lett. 2010, 469:155-158.
32. Godeiro-Junior C., de Carvalho-Aguiar P.M., Felício A.C., et al. PINK1 mutations in a Brazilian cohort of early-onset Parkinson's disease patients. Mov. Disord. 2009, 24:1693-1696.
33. Zhang B.R., Hu Z.X., Yin X.Z., et al. Mutation analysis of parkin and PINK1 genes in early-onset Parkinson's disease in China. Neurosci. Lett. 2010, 477:19-22.
34. Bras J., Guerreiro R., Ribeiro M., et al. Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2. BMC Neurol. 2008, 8:1.
35. Mellick G.D., Siebert G.A., Funayama M., et al. Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia. Parkinsonism Relat. Disord. 2009, 15:105-109.
36. Biswas A., Sadhukhan T., Majumder S., et al. Evaluation of PINK1 variants in Indian Parkinson's disease patients. Parkinsonism Relat. Disord. 2010, 16:167-171.
37. Tan E.K., Yew K., Chua E., et al. PINK1 mutations in sporadic early-onset Parkinson's disease. Mov. Disord. 2006, 21:789-793.